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Background {#sec005}
==========

COPD (Chronic Obstructive Pulmonary Disease) is a life-threatening lung disease characterised by persistent airflow limitation that interferes with normal breathing and is fully non- reversible \[[@pone.0233488.ref001]\]. Multi-morbidity among COPD patients contributes to the overall severity and increases the economic burden of treatment and health service costs \[[@pone.0233488.ref002], [@pone.0233488.ref003]\]. The World Health Organisation (WHO) reports that COPD caused 3.17 million (5%) deaths in 2015 world-wide and is anticipated to be in third position among all leading causes of death by 2020 \[[@pone.0233488.ref004]\]. The prevalence of COPD is increasing in Nepal. Subnational studies from Nepal reported the prevalence's of COPD ranging from 23% to 43% \[[@pone.0233488.ref005], [@pone.0233488.ref006]\].

Research has shown that improved health literacy has been associated with improvement in life style behaviours for chronic disease and decreased rates of hospitalisation \[[@pone.0233488.ref007], [@pone.0233488.ref008]\]. Quality of care for all chronic illness relies on informed, activated consumers and health care policy focusing on strategies related to informing and engaging patients \[[@pone.0233488.ref009]\].

The WHO defined health literacy as 'the personal characteristics and social resources needed for individuals and communities to access, understand, appraise and use information and services to make decisions about health' \[[@pone.0233488.ref010]\]. This definition broadens the concept of Health Literacy as 'skill set', by including consumers' motivation or 'mindset', which is crucial for engaging in healthy lifestyle behaviours \[[@pone.0233488.ref011]\]. The term 'patient and consumer activation/motivation' is specifically defined as those who have the motivation, knowledge, skills and confidence to make effective decisions to manage their overall health \[[@pone.0233488.ref012]\], rather than focusing on a specific behaviour (e.g. Quitting smoking, getting involved in the physical activity) known as self-efficacy. Hibbard and colleagues developed a comprehensive scale to measure activation of patients for managing their health known as the Patient Activation Measure (PAM) \[[@pone.0233488.ref013]\]. Research has identified age, educational attainment, socioeconomic status, cultural beliefs and practices and communication (including language barriers) between professionals and patients as the determinants for low health literacy \[[@pone.0233488.ref014], [@pone.0233488.ref015]\]. Other determinants include symptom burden, illness perception, and presence of comorbidities, age, body mass index, physical health status, depression, social support, financial distress and lack of understanding their role in care process associated with lower patient activation \[[@pone.0233488.ref016], [@pone.0233488.ref017]\].

A study from a tertiary level hospital from eastern Nepal reported low levels of health literacy and knowledge related to chronic disease \[[@pone.0233488.ref018]\]. In this study, authors identified older age and being female, having low or no education, unemployment or retired status, poverty and history of smoking or consuming alcohol as being associated with inadequate health literacy. Health literacy was found to be strong predictor of knowledge regarding hypertension, diabetes mellitus and COPD.

In recent years, the Government of Nepal has prioritised chronic conditions and is committed to deliver the services in line with National Multisectoral Action Plan(2014--2020) for the Prevention and Control of Non-Communicable Diseases \[[@pone.0233488.ref019]\]. One important objective of this plan was to prevent and control of NCDs by addressing the underlying social determinants of the health, through people-centred primary health care. In this light, emerging evidence \[[@pone.0233488.ref020]\] advocates that building health literacy could play an essential role in prevention, adherence to treatment, self-management, modification of unhealthy behaviours and the utilisation of the available health care services. HL and PA are important in supporting self-management practices for COPD patients where understanding of HL and PA levels is very important. There is no specific study that accessed the level of HL and PAM and their determinants focusing COPD patients from the community setting of Nepal. Our study aimed at examining the levels and determinants of HL and PA among the multi-morbid COPD patients in Nepal.

Materials and methods {#sec006}
=====================

Study design and participants {#sec007}
-----------------------------

This was a community-based prospective cross-sectional study among multi-morbid COPD adults living in two rural municipalities of *Sunsari* district, Nepal. The study was carried out in between July 2018-January 2019. Simple random sampling was used to select the study participants from the study area. The sample size of 250 was calculated based on following assumptions: prevalence (knowledge on self-management) = 18% \[[@pone.0233488.ref021]\], sampling error = 5.0%, CI = 95.0%, and non-response rate = 10.0%. In the beginning, two Rural Municipalities (RMs) were randomly selected from the list of six RMs in *Sunsari* District. The list of the 576 individuals (296 from rural municipality A and 280 from rural municipality B considering the probability proportion to size) was prepared before conducting the field work, i.e., collecting the patient records from primary health care center (PHC) and health posts (HPs) of the study area. The data on people with COPD seeking service at private hospitals for COPD along with those seeking services private setting hospitals were collected with the help of Female Community Health Volunteers (FCHV), and the research assistant verified the data for such patients by looking through their medical records. Per protocol, 250 people with COPD were selected randomly from the list of eligible subjects. 238 people with COPD met the eligibility criteria for this study and were interviewed by the two trained interviewers in the community setting.

People with COPD were eligible to participate if they were adults aged between 18--70 years; had been diagnosed with COPD with at least one co-morbidity such as cardiovascular disease, diabetes, asthma, arthritis, depression, musculoskeletal disorders or gastritis in their medical records; and had been able to understand the information sheet or consent form. The informed consent form was read by the research assistants for those who were unable to read. All of the participants were informed that they were free to withdraw or opt out at any point during the interview. Prior to the interview, written informed consent was obtained from all literate participants, and thumb impressions were obtained from illiterate participants. Study participants with a hearing disability, severe cognitive disorder, kidney disease, a history of stroke or diagnosed heart attack and with terminal illness such as cancer were excluded from the study.

Procedure {#sec008}
---------

Interviewer-administered data collection was conducted over three months where participants provided information on socio-demographic items, a health literacy measure and, a measure of patient activation. Two-day' hands-on training was provided to the RAs by one of the researchers of this study group which included field activities where they explained the questions and checked the understanding. In the pilot, we checked responses for inconsistency and did not find any evidence of inconsistency. The data collection was performed by trained RAs who were fluent in both Maithili (a local language spoken by chunks in a rural setting) and a Nepali language. The first author monitored the field in the community settings.

Measurement {#sec009}
-----------

### Health literacy {#sec010}

It was measured by using five of the nine domains of the Health Literacy Questionnaire (HLQ) \[[@pone.0233488.ref022]\]. The five domains were chosen based on relevance in the local context of Nepal. The HLQ domains were discussed between the research team and some of the experts from Nepal and the agreement was reached on using five domains. Of the excluded domain, three domains of HLQ were not relevant to Nepalese context and one domain was redundant because the PAM was also included. HLQ domains included in our study are: (i) feeling understood and supported by healthcare providers (HPS): four items, (ii) having sufficient information to manage my own health (HIS): four items, (iii) social support for health (SS: five items (iv) ability to find the good health information (AE): five items, and (v) understand the health information well enough to know what to do (UHI): five items. The logic behind the use of HLQ is that it measures the multidimensional health literacy profile, and the scales we used were culturally relevant to our setting. For the domains 1 to 3: participants responded as strongly disagree = 1, disagree = 2, agree = 3, strongly agree = 4 and for the domains 4 to 5: participant responded as cannot do = 1, very difficult = 2, quite difficult = 3, quite easy = 4, very easy = 5.The overall domain score was calculated by adding the item scores and then dividing by the number of items in that specific domain \[[@pone.0233488.ref023]\]. The cut-offs to define "high health literacy level" was determined considering upper quartile and the lower two quartiles as "low health literacy level". This applied to categorize all the five HLQ domains as there was no any standard cut-off.

### Patient activation {#sec011}

The shortened Nepali version of the PAM (13-item) was used to access the self-reported knowledge, skill and confidence required for self-management of conditions \[[@pone.0233488.ref024]\]. This is a very reliable measure that captures aspects of motivation and engagement with self-management behaviors and health conditions. The 13 items have four possible responses option ranging from (i) strongly disagree to (iv) strongly agree, and an additional \"not applicable\" option and total scores of PAM ranges from 0--100. The raw score was calculated using a password protected scoresheet provided by Insignia Health and then excel data was imported in SPSS \[[@pone.0233488.ref025]\]. The raw scores for PAM were converted into four activation levels: (i) Level 1(0.0--47.0): disengaged and overwhelmed, (ii) Level 2(47.1--55.1): becoming aware, but still struggling, (iii) Level 3(55.2--72.4): taking action and, (iv) Level 4(72.5--100.0): maintaining behaviors and pushing = more \[[@pone.0233488.ref025], [@pone.0233488.ref026]\]. We further categorized level 1 was as "poor activation stage" and Level 2 to 4 as "activation" stage.

### Independent variable measurement {#sec012}

Independent variable included age; gender; marital status; religion; ethnicity; educational attainment; occupation status; income and, use of tobacco products. Similarly, the illness perception was measured using a nine-item scale brief illness perception questionnaire (BIPQ) \[[@pone.0233488.ref027]\] designed to assess the cognitive and emotional representations of illness rapidly. The higher the mean score of BIPQ, the greater negative reactions towards disease.

The English version of the socio-demographic profiles; HLQ and BIPQ were first translated to Nepali and then translated back to English by two external persons who were fluent in both Nepali and English language to check for consistency. The Nepali version of HLQ, BIPQ and PAM were used to collect the information from the participants and these tools have been used previously \[[@pone.0233488.ref028]--[@pone.0233488.ref031]\] in Nepal. The Cronbach\'s alpha for each scale was found to be above 0.8.

Ethics {#sec013}
------

The study received ethical approval from Human Research Ethics Committee (HREC) of University of New South Wales (UNSW), Sydney, Australia (HC180502), and the Nepal Health Research Council (Reg no 495). The study participants did not receive any benefits during their involvement in the research and written informed consent was obtained from all respondents prior to the interview.

Statistical analyses {#sec014}
--------------------

The statistical analyses were performed using the IBM Statistical Package for Social Sciences (SPSS 23.00) \[[@pone.0233488.ref032]\]. Participant characteristics were summarized as frequency and percentage. Normality of the data was assessed using Shapiro-Wilk test. Inter-quartile range was calculated for all included HLQ domains separately, where the upper quartile cut-offs was used to define "high health literacy level" and the lower two quartiles as "low health literacy level". The raw scores for PAM were categorized into four activation levels (Level 1, 2, 3 and 4) based on standard cut-off of PAM where level 1 was labelled as "poor activation stage" and Level 2 to 4 as "activation" stage. We used Chi-Square test for univariate analysis was conducted for all included five domains of HLQ and the PAM where all the independent variables that had p\<0.2 were considered in multivariable regression analysis. We assessed multicollinearity of covariates using Variance Inflation Factors (VIFs). The VIFs for all covariates that were included in the logistic regression analysis were less than 2.0. Backward elimination stepwise multivariable logistic regression analysis was performed to identify the determinants of poor HL and PA levels and the p-value ≤ 0.05 were considered as significant. The Hosmer-Lemeshow test was used for goodness of fit in the logistic regression model.

Results {#sec015}
=======

Overall, data of 238 participants were included in the analysis and are presented in [Table 1](#pone.0233488.t001){ref-type="table"}. Study participants varied by gender, age group, education, marital status, the religion they practice, ethnicity, occupation, family level income, use of tobacco products and the presence of co-morbidities. Majority of tobacco users were found using smoking form of tobacco products like cigarettes, Bidis (small hand-rolled cigarettes made of tobacco and wrapped in leaf), Chillums (a straight conical pipe with end-to-end channel used for smoking).The majority of the participants had a high illness burden (BIPQ mean 49.83, SD = 8.86).

10.1371/journal.pone.0233488.t001

###### Characteristics of study samples.

![](pone.0233488.t001){#pone.0233488.t001g}

  Characteristics                                                   n                                                                                                                             \%
  ----------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------- ------
  **Gender**                                                                                                                                                                                      
  Male                                                              107                                                                                                                           45
  Female                                                            131                                                                                                                           55
  **Age category (in years)**                                                                                                                                                                     
  ≤40                                                               18                                                                                                                            7.6
  41--55                                                            44                                                                                                                            18.5
  ≥56                                                               176                                                                                                                           73.9
  **Education status**                                                                                                                                                                            
  Uneducated(not able to read and write)                            166                                                                                                                           69.7
  Educated(able to read and write)                                  72                                                                                                                            30.3
  **Marital status**                                                                                                                                                                              
  Married                                                           176                                                                                                                           73.9
  Unmarried/divorced/widow/widower                                  62                                                                                                                            26.1
  **Ethnicity**                                                                                                                                                                                   
  Brahmin/Chhetri (Higher caste)                                    98                                                                                                                            41.2
  Indigenous                                                        91                                                                                                                            38.2
  Dalits(untouchable caste as per traditional Hindu caste system)   49                                                                                                                            20.6
  **Religion**                                                                                                                                                                                    
  Hindu                                                             222                                                                                                                           93.3
  Islam                                                             16                                                                                                                            6.7
  **Occupation**                                                                                                                                                                                  
  Farmer/Housewife                                                  108                                                                                                                           45.4
  Professional jobs (Business/government jobs/private company)      8                                                                                                                             3.4
  Factory workers/labourers                                         122                                                                                                                           51.3
  **Family income level(**1USD = 113.63 NPR)                                                                                                                                                      
  ≲20,000                                                           206                                                                                                                           86.6
  \>20000                                                           32                                                                                                                            13.4
  **Use of tobacco product\***                                                                                                                                                                    
  No                                                                45                                                                                                                            18.9
  Yes                                                               193                                                                                                                           81.1
  **Presence of co-morbidity**                                                                                                                                                                    
  At least one                                                      60                                                                                                                            25.2
  Two or more                                                       178                                                                                                                           74.8
  **Health literacy Questionnaire**                                                                                                                                                               
  ***HPS***                                                                                                                                                                                       
  Low                                                               188                                                                                                                           79.0
  High                                                              50                                                                                                                            21.0
  ***HIS***                                                                                                                                                                                       
  Low                                                               182                                                                                                                           76.5
  High                                                              56                                                                                                                            23.5
  ***SS***                                                                                                                                                                                        
  Low                                                               184                                                                                                                           77.3
  High                                                              54                                                                                                                            22.7
  ***AE***                                                                                                                                                                                        
  Low                                                               179                                                                                                                           75.2
  High                                                              59                                                                                                                            24.8
  ***UHI***                                                                                                                                                                                       
  Low                                                               178                                                                                                                           74.8
  High                                                              60                                                                                                                            25.2
  **Patient activation measure (PAM)**                                                                                                                                                            
  Level 1                                                           194                                                                                                                           81.5
  Level 2                                                           28                                                                                                                            11.8
  Level 3                                                           12                                                                                                                            5
  Level 4                                                           4                                                                                                                             1.7
  **Total brief illness perception scale(n = 238)**                 \-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--   

HPS: Feeling understood and supported by healthcare providers.

HIS: Having sufficient information to manage my own health.

SS: Social support for health.

AE: Ability to find the good health information.

UHI: understand the health information well enough to know what to do.

Levels of HL and PA {#sec016}
-------------------

Based on HLQ multi-dimensional scale, the proportion of people with low literacy level across the scales was: (i) HPS (79.0%), (ii) HIS (76.5%), (iii) SS (77.3%) (iv) AE (75.2%), and (v) UHI (74.8%),respectively. The majority of these patients reported low levels of patient activation (level 1, 81.5%; level 2, 11.8%), only 6.7% (level 3, 5%; level 4, 1.7%) reported higher patient activation level \[[Table 1](#pone.0233488.t001){ref-type="table"}\].

The mean scores for HLQ domains and patient activation are presented in [Table 2](#pone.0233488.t002){ref-type="table"}. The mean (SD) for HLQ domains: (i) HPS (1.96±.76), (ii) HIS (1.56±.74), (iii) SS (2.73±.77), (iv) AE (2.02±1.10), and (v) UHI (1.78±.99). The mean PAM score was 34.18 (14.20).

10.1371/journal.pone.0233488.t002

###### Univariate analysis to identify the determinants of health literacy questionnaire and PAM.

![](pone.0233488.t002){#pone.0233488.t002g}

                                                         HPS                   HIS                   SS                    AE                    UHI                   PAM                                                                
  ------------------------------------------------------ --------------------- --------------------- --------------------- --------------------- --------------------- --------------------- -------- -------- -------- -------- -------- ----
  **Gender**                                             0.41                  ***0*.*07\****        *0*.*87*              ***\<0*.*001\*\****   ***\<0*.*001\****     ***0*.*18\*\*\****                                                 
  Male                                                   82                    25                    76                    31                    82                    25                    68       39       68       39       83       24
  (76.6)                                                 (23.4)                (71.0)                (29.0)                (76.6)                (23.4)                (63.6)                (36.4)   (63.6)   (36.4)   (77.6)   (22.4)   
  Female                                                 25                    106                   106                   25                    102                   29                    111      20       110      21       111      20
  (19.1)                                                 (80.9)                (80.9)                (19.9)                (77.9)                (22.1)                (84.7)                (15.3)   (84.0)   (16.0)   (84.7)   (15.3)   
  **Age category(in years)**                             *0*.*55*              ***0*.*03\****        *0*.*71*              ***0*.*04\****        ***0*.*05\****        ***0*.*18\*\*\****                                                 
  ≤40                                                    13                    5                     11                    7                     14                    4                     13       5        10       8        13       5
  (72.2)                                                 (27.8)                (61.1)                (38.9)                (77.8)                (22.2)                (72.2)                (27.8)   (55.6)   (44.4)   (72.2)   (27.8)   
  41--55                                                 33                    11                    29                    15                    36                    8                     27       17       30       14       33       11
  (75.0)                                                 (25.0)                (65.9)                (34.1)                (81.8)                (18.8)                (61.4)                (38.6)   (68.2)   (31.8)   (75.0)   (25.0)   
  ≥56                                                    142                   34                    142                   34                    134                   42                    139      37       138      38       148      28
  (80.7)                                                 (19.3)                (80.7)                (19.3)                (76.1)                (23.9)                (79.0)                (21.0)   (78.4)   (21.6)   (84.1)   (15.9)   
  **Education status**                                   ***\<0*.*001\*\****   ***\<0*.*001\*\****   ***0*.*02\****        ***\<0*.*001\*\****   ***\<0*.*001\*\****   ***\<0*.*001\*\****                                                
  Uneducated                                             143                   23.0                  141                   25                    135                   31                    147      19       148      18       145      21
  (86.1)                                                 (13.9)                (84.9)                (15.1)                (81.3)                (18.7)                (88.6)                (11.4)   (89.2)   (10.8)   (87.3)   (12.7)   
  Educated                                               45                    27                    41                    31                    49                    23                    32       40       30       42       49       23
  (62.5)                                                 (37.5)                (56.9)                (43.1)                (68.1)                (31.9)                (44.4)                (55.6)   (41.7)   (58.2)   (68.1)   (31.9)   
  **Marital status**                                     ***\<0*.*001\*\****   ***0*.*02\****        *0*.*71*              ***\<0*.*001\*\****   ***\<0*.*001\*\****   ***\<0*.*001\*\****                                                
  Married                                                131                   45                    128                   48                    135                   41                    124      52       122      54       139      37
  (74.4)                                                 (25.6)                (72.7)                (27.3)                (76.7)                (23.3)                (70.5)                (29.5)   (69.3)   (30.7)   (79.0)   (21.0)   
  Others                                                 57                    5                     54                    8                     49                    13                    55       7        56       6        55       7
  (91.9)                                                 (8.1)                 (87.1)                (12.9)                (79.0)                (21.0)                (88.7)                (11.3)   (90.3)   (9.7)    (88.7)   (11.3)   
  **Ethnicity**                                          *0*.*56*              *0*.*96*              ***\<0*.*001\*\****   *0*.*28*              *1*.*00*              ***0*.*16\*\*\****                                                 
  Higher Caste                                           78                    20                    75                    23                    65                    33                    73       25       73       25       85       13
  (79.6)                                                 (20.4)                (76.5)                (23.5)                (66.3)                (33.7)                (74.5)                (25.5)   (74.5)   (25.5)   (86.7)   (13.3)   
  Indigenous                                             69                    22                    69                    22                    74                    17                    65       26       68       23       69       22
  (75.8)                                                 (24.2)                (75.8)                (24.2)                (81.3)                (18.7)                (71.4)                (28.6)   (74.7)   (25.3)   (75.8)   (24.2)   
  Dalits                                                 41                    8                     38                    11                    45                    4                     41       8        37       12       40       9
  (83.7)                                                 (16.3)                (77.6)                (22.4)                (91.8)                (8.2)                 (83.7)                (16.3)   (75.5)   (24.5)   (81.6)   (18.4)   
  **Occupation**                                         ***\<0*.*001\*\****   ***\<0*.*001\*\****   *0*.*25*              ***\<0*.*001\*\****   ***\<0*.*001\*\****   ***\<0*.*001\*\****                                                
  Professionals(Government jobs, Private, Businessman)   4                     4                     4                     4                     5                     3                     3        5        3        5        5        3
  (50.0)                                                 (50.0)                (50.0)                (50.0)                (62.5)                (37.5)                (37.5)                (62.5)   (37.5)   (62.5)   (62.5)   (37.5)   
  Farmer/housewife                                       74                    34                    70                    38                    88                    20                    75       33       73       35       76       32
  (68.5)                                                 (38.5)                (64.8)                (35.2)                (81.5)                (18.5)                (69.4)                (30.6)   (67.6)   (32.4)   (70.4)   (29.6)   
  Factory workers/labourers                              110                   12                    108                   14                    91                    31                    101      21       102      20       113      9
  (90.2)                                                 (9.8)                 (88.5)                (11.5)                (74.6)                (25.4)                (82.8)                (17.2)   (83.6)   (16.4)   (92.6)   (7.4)    
  **Family level income**                                ***0*.*04\****        0.51                  ***0*.*04\****        ***\<0*.*001\*\****   ***0*.*04\****        0.59                                                               
  \<20,000                                               167                   39                    159                   47                    164                   42                    162      44       159      47       169      37
  (81.1)                                                 (18.9)                (77.2)                (22.8)                (79.6)                (20.4)                (78.6)                (21.4)   (77.2)   (22.8)   \(82\)   \(18\)   
  \>20,000                                               21                    11                    23                    9                     20                    12                    17       15       19       13       25       7
  (65.6)                                                 (34.4)                (71.9)                (28.1)                (62.5)                (37.5)                (53.1)                (46.9)   (59.4)   (40.6)   (78.1)   (21.9)   
  **Use of tobacco products**                            ***0*.*07\****        ***0*.*01\****        0.66                  0.57                  ***0*.*08\****        ***0*.*13\*\*\****                                                 
  No                                                     31                    14                    28                    17                    35                    10                    32       13       29       16       161      32
  (68.9)                                                 (31.1)                (62.2)                (37.8)                (77.8)                (22.2)                (71.1)                (28.9)   (64.4)   (35.6)   (83.4)   (16.6)   
  Yes                                                    157                   36                    154                   39                    149                   44                    147      46       149      44       33       12
  (81.3)                                                 (18.7)                (79.8)                (20.2)                (77.2)                (22.8)                (76.2)                (23.8)   (77.2)   (22.8)   (17.3)   (26.7)   
  **Presence of co-morbidity**                           0.36                  ***0*.*14\*\*\****    0.21                  1                     0.74                  0.45                                                               
  At least one                                           138                   40                    132                   46                    134                   44                    134      44       132      46       143      35
  (77.5)                                                 (22.5)                (74.2)                (25.8)                (75.3)                (24.7)                (75.3)                (24.7)   (74.2)   (25.8)   (80.3)   (19.7)   
  Two or more                                            50                    10                    50                    10                    50                    10                    45       15       46       14       51       5
  (83.3)                                                 (16.3)                (83.3)                (16.7)                (83.3)                (16.7)                (75.0)                (25.0)   (76.7)   (23.3)   (85.0)   (15.0)   
  Total illness perception scale (Mean± SD)              49.83±8.86                                                                                                                                                                       

p-value\*\*\*\<0.2, p-value\* \<0.05, p-value\*\* \<0.001.

HPS: Feeling understood and supported by healthcare providers.

HIS: Having sufficient information to manage my own health.

SS: Social support for health.

AE: Ability to find the good health information.

UHI: understand the health information well enough to know what to do.

Associations with low HL scores across the HLQ domains {#sec017}
------------------------------------------------------

[Table 2](#pone.0233488.t002){ref-type="table"} presents univariate results for the associates of low HL and poor activation levels among our study samples.

Multivariate logistic regression analyses ([Table 3](#pone.0233488.t003){ref-type="table"}) found significant associations between low health literacy level and socio-demographic variables: HPS domain was associated with having no education (AOR = 3.01, 95% CI: 1.44--6.29); HIS domain was associated with being female(AOR = 2.31, 95% CI: 1.02--5.23) or having no education (AOR = 3.11, 95% CI: 1.48--6.55); SS domain was associated with being *Indigenous* (AOR = 2.27, 95% CI: 1.14--4.50) or *Dalit* (AOR = 4.84, 95% CI: 1.57--14.83); AE domain was associated with being female (AOR = 2.56, 95% CI: 1.12--5.83), having no education (AOR = 6.40, 95% CI: 2.98--13.76), or having a family income level ≥ USD 176(AOR = 3.06, 95% CI: 1.17--8.04); UHI domain was associated with being female(AOR = 3.12, 95% CI: 1.28--7.59), or having no education (AOR = 7.06, 95% CI: 3.33--14.96) respectively.

10.1371/journal.pone.0233488.t003

###### Stepwise multivariable logistic regression analysis for low health literacy and a poor activation stage on PAM.

![](pone.0233488.t003){#pone.0233488.t003g}

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                         AOR(95% CI)                                                                                                           
  ------------------------------------------------------ ----------------------- ---------------------- ---------------------- ----------------------- ----------------------- ----------------------
  **Gender**                                                                                                                                                                    

  Male                                                   *NI*                    1                       *NI*\                 1                       1                       1

  Female                                                 **2.31(1.02--5.23)**    **2.56(1.12--5.83)**   **3.12(1.28--7.59)**   2.04(.86--4.80)                                 

  **Age category (in years)**                                                                                                                                                   

  ≤40                                                    \                       1                      \                      1                       1                       1
                                                         *NI*                                           *NI*\                                                                  

  41--55                                                 .73(.18--2.86)          .51(.12--2.17)         1.50(.35--6.33)        .89(.21--3.73)                                  

  ≥56                                                    .68(.27--1.67)          1(.25--3.98)           1.26(.30--5.30)        .89(.20--3.90)                                  

  **Education status**                                                                                                                                                          

  Educated                                               **1**                   **1**                  1                      **1**                   **1**                   **1**

  Uneducated                                             **3.01(1.44--6.29)**    **3.11(1.48--6.55)**   1.79(.91--3.12)        **6.40(2.98--13.76)**   **7.06(3.33--14.96)**   **2.42(1.09--5.38)**

  **Marital status**                                                                                                                                                            

  Married                                                1                       1                      \                      1                       1                       1
                                                                                                        *NI*                                                                   

  Others                                                 2.63(.94--7.35)         1.45(.58--3.58)        .49(.18--1.33)         .38(.13--1.10)          1.05(.39--2.85)         

  **Ethnicity**                                                                                                                                                                 

  Higher Caste                                           \                       \                      1                                              1                       1
                                                         *NI*\                   *NI*\                                                                                         

  Indigenous                                             **2.27(1.14--4.50)**    .85(.38--1.90)         .55(.18--1.61)         .57(.25--1.32)                                  

  Dalits                                                 **4.84(1.57--14.83)**   1.06(.37--3.07)        .52(.12--2.20)         .37(.13--1.1)                                   

  **Occupation**                                                                                                                                                                

  Professionals(Government jobs, Private, Businessman)   1                       1                      \                      1                       1                       1
                                                                                                        NI                                                                     

  Farmer/housewife                                       1.34(.26--6.79)         .58(.12--2.90)         1.21(.21--7.01)        .95(.17--5.29)          .80(.16--3.92)          

  Factory workers/labourers                              4.61(.82--25.72)        2.16(.41--11.32)       2.16(.36--12.93)       2.36(.41--13.58)        4.6(.85--25.42)         

  **Family level income**                                                                                                                                                       

  \<20,000                                               1.84(.74--4.52)         \                      1.87(.81--4.31)        **3.06(1.17--8.04)**    2.06(.78--5.44)         *NI*
                                                                                 *NI*                                                                                          

  \>20,000                                                                       1                      1                      1                                               

  **Use of tobacco products**                                                                                                                                                   

  No                                                     1                       1                       *NI*\                 \                       1                       1
                                                                                                                               *NI*                                            

  Yes                                                    1.31(.58--2.97)         2.25(.86--5.86)        2.04(.70--5.96)        1.78(.62--5.09)                                 

  **Presence of co-morbidity**                                                                                                                                                  

  At least one                                            *NI*\                  2.25(.93--5.46)        \                      \                       * NI*                   \
                                                                                                        *NI*                   *NI*                                            *NI*

  Two or more                                            1                                                                                                                     

  **Total illness perception scale**                     .99(.96--1.03)          .98(.95--1.02)         .99(.96--1.03)         .99(.95--1.03)          1.01 (.97--1.05)        **1.01(1.00--1.11)**
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Model is adjusted for the all variables that are considered in each model.

NI: not included in the particular model.

HPS: Feeling understood and supported by healthcare providers.

HIS: Having sufficient information to manage my own health.

SS: Social support for health.

AE: Ability to find the good health information.

UHI: understand the health information well enough to know what to do.

Associations with low PAM score {#sec018}
-------------------------------

Poor activation (levels 1) was associated with having no education (AOR = 2.42, 95% CI: 1.09--5.38), or poor patients illness perception (AOR = 1.01, 95% CI: 1.00--1.11).

Discussion {#sec019}
==========

Health literacy \[[@pone.0233488.ref033]\] and activation levels \[[@pone.0233488.ref034]\] are foundational for the prevention and management of long-term conditions. The presence of co-morbidity among the chronic disease patients poses a significant and long-term challenge for patients, health services provider and the countries health care system. There is a scarce data on HL and PA among the multi-morbid COPD patients from the community setting in Nepal. A few studies have assessed HL, but none have measured both HL and PAM among chronic disease patients. To the best of our knowledge we are the first to examine the levels, relationship and determinants of health literacy and patient activation in multi-morbid COPD people in Nepal.

PA and HL levels {#sec020}
----------------

In the present study three quarters of participants had low health literacy levels across the five domains of HLQ. Patients with lower HL had difficulty in feeling understood and supported by healthcare providers, had insufficient information to manage their own health, were unable to find good health information or understand health information well enough to know what to do. If their level of health literacy is low, people may not be able to navigate the health system. Moreover, they lack the knowledge, may be misinformed about the cause of disease or may not understand the importance of relationship between lifestyle behaviours and health outcomes.

A recently published study from Nepal conducted among chronic disease patients recruited from tertiary level hospital and a community hospital using Europe-Asia Health Literacy Survey Questionnaire showed 19% had marginal HL and 54% had inadequate HL \[[@pone.0233488.ref018]\]. Overall, a higher proportion of patients had low literacy in our study population when compared with studies from India \[[@pone.0233488.ref035]\] and Bangladesh \[[@pone.0233488.ref036]\]. Similarly, the estimate is higher than that reported among COPD patients in the United Kingdom (15%) \[[@pone.0233488.ref037]\], Spain(59%) \[[@pone.0233488.ref038]\], Europe(47%) \[[@pone.0233488.ref039]\] or the United States of America (29%) \[[@pone.0233488.ref040]\]. The higher estimate of low HL could be explained by a larger proportion of the participants had no formal education and also had limited right information about the availability of health services for respiratory conditions at a primary health care or other health care setting in Nepal.

Similarly, a high proportion of multi-morbid COPD patients demonstrated a low level (level 1:81.5%) of activation. We could not find any study from Nepal on PAM levels to compare with our study findings. A hospital-based study from India has shown that nearly 50% (level 1:21.88, level 2: 25.57) of the sample were at a low level of activation \[[@pone.0233488.ref041]\]. In contrast to our findings, studies from the Australia \[[@pone.0233488.ref042]\], Netherlands \[[@pone.0233488.ref043]\], and USA \[[@pone.0233488.ref017]\] reported lower proportions of less activated patients. In this study, the mean scores on the PAM-13 were much lower than aforementioned studies from India, Australia, Netherlands and USA. In our study, a lower level of activation might be explained by participants having one or more multi-morbid conditions. The low activation level is plausible; given that in the rural part of Nepal where illiteracy is high, people with chronic disease might not have received adequate support from family members/care givers and health care professionals to manage their conditions. More importantly, activation might have differed across gender, ethnicity, age, education and income level and few of these have been reported to be correlated with activation levels in previous studies \[[@pone.0233488.ref017], [@pone.0233488.ref044]\]. Moreover, social-desirable bias might have leaded to overstate responses.

Associates of HL and PAM {#sec021}
------------------------

Importantly, having no education was significantly associated with low HL levels across four domains of the HLQ. Patients with poor levels of education find difficulty in understanding the information provided by health care providers, don\'t have enough information for management of their conditions and, have poorer ability to find and understand health information. In the Nepalese context, many uneducated people are indiscriminate in their search for information about the conditions and medications, delay seeking the available health services and find difficulty communicating with health professionals about their health conditions. They often they seek information from other educated people, teachers and mid-level health professionals. Having no education deprives them of getting better jobs, having a good income and thus limits their timely access to health service which in turn may lead to poor health actions required for managing conditions. Previous studies support our findings on educational attainment \[[@pone.0233488.ref040], [@pone.0233488.ref045], [@pone.0233488.ref046]\] as an important determinant for lower health literacy. Thus, there is need to close the gap between what healthcare professionals knows and provide, and what the people with no education understands and use the information for decision making. Adopting teach-back process could be a good way to address the HL at the care delivery level (primary health care centres, clinics or hospital) so that patients don't miss appointment, can have enough knowledge of disease and healthy lifestyle habits, and be able to understand the medications and the purpose of taking medications.

Consistent with other research, we found that being female \[[@pone.0233488.ref047], [@pone.0233488.ref048]\] was a determinant of lower HL level across three domains of HL (HIS, AE, UHI). In our study, females were less empowered with their role restricted to household activities. Women in rural area (particularly in rural Terai region) have less autonomy in decision making about their own health because of unequal access to education and health care \[[@pone.0233488.ref049]\]. This study was conducted in the plains region of Nepal, where the majority of populations are unprivileged (Madeshi, Indigenous and Dalits origin), where women do not have the ability to find sufficient health information. Thus, an approach that is gender based may be required to improve patient health literacy. Another study from Nepal supports our finding that being female was associated with poor health literacy \[[@pone.0233488.ref018], [@pone.0233488.ref050]\]. In contrast, evidence from China did not find a relationship between gender and HL while a study from the US, showed females had higher HL, possible due the difference in socio-demographic profiles of the studied populations \[[@pone.0233488.ref011], [@pone.0233488.ref051]\]. In line with our findings, published work has shown that not being married or divorced were associated with poor health literacy \[[@pone.0233488.ref040]\]. Interestingly, families with low incomes were more likely to have low HL in the AE domain of the HLQ. This could be because the patients from low-income level family might not seek health services and ignore the health problems because of the financial barrier to their access. Moreover, ability to find good information about the conditions and available services may not be a priority in comparison with other daily living needs such as employment, farming etc. Supporting our findings, other authors have reported family income to be a determinant for HL \[[@pone.0233488.ref040], [@pone.0233488.ref044], [@pone.0233488.ref051]\].

More than half of the participants who were from *Indigenous and Dalits* community were more likely to have poor health literacy on the SS domain. The one potential explanation could be poor socio-economic status of the family/caregivers in this community. For instance, a financially challenged caregiver might not be able to fulfil the daily needs and take a proper care of the health of people with chronic diseases such as COPD. Furthermore, the poor socio-cultural environment of the disadvantaged ethnic groups may result in caregivers being unwilling to listen to the health problems of the older family member with condition like COPD and to provide them with the support they need \[[@pone.0233488.ref052]--[@pone.0233488.ref054]\].

We found that having no education and poor illness perception was associated with poor levels of activation. This is supported by other evidence demonstrating that being uneducated was associated with lower PAM \[[@pone.0233488.ref044]\]. Association between illness perception and PAM scores was also supported by the findings of other studies \[[@pone.0233488.ref016], [@pone.0233488.ref017]\]. A high illness perception score reflects patients 'experience of fear, threat, breathlessness and poor emotional responses to the disease. This might have a significant impact on the quality of life of people with COPD \[[@pone.0233488.ref055]\]. Thus, we suggest the need to address illness perception as an important predictor for activating the patients to engage in self-management of behaviours.

In sum up, our findings underscore the need for a program that is tailored to patient HL and activation levels, and which supports or develops decision-making, goal setting and self-management skills. Such a program must include activities to increase awareness of disease and conditions, improve communication skills with health professionals. It also needs to improve access to quality information on their conditions and medications, diet and exercise and creates an enabling environment. Moreover, health care providers need to be aware that HL and PA are different but correlated and must both taken into consideration while planning care. These results provide compelling evidence to integrate HL and PA initiatives in all health policies aimed at improving the behaviour change required for self-management of the conditions in this population.

Strength of this study is that it is one of the first studies of its kind to assess the HL and PA among the multi-morbid COPD patients in rural Nepal. A limitation is that the study was conducted in two rural municipalities of the Sunsari district, thus, the results cannot be generalised to other settings of Nepal. Additionally, we have relied on government data and medical records of patients and have not verified the cases with any objective measures. Further, this study was cross-sectional in nature and thus the causal relationship between the dependent and independent variables cannot be established.

Conclusion {#sec022}
==========

In conclusion, a high proportion of multi-morbid COPD patients had low levels of HL and were less activated that was required for self-management of COPD. Having no education, being female, a monthly family income less than USD176 and being from indigenous and Dalit communities, were associated with lower level of health literacy. Low education attainment and poor illness perception were associated with being less activated in their care. Addressing both levels and determinants of HL and patient activation is required to improve self-management practices among COPD patients.

Supporting information {#sec023}
======================
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I would take this opportunity to thank you and the reviewers for your valuable remarks. We authors have addressed all the remarks and have improved the quality of paper. In particular, we revised our analysis using logistic regression method.

Once again, many thanks for your valuable remarks.

Looking forward to hearing from you.

Warm Regards,

Uday

Editor remarks

Please clarify scoring and categorization of HQL and PAM in more detail. We used the PAM questionnaire as an instrument to measure Customer Quality in our work as a third dimension to quality. You can find more detail in \"Gholipour K, Tabrizi JS, Jafarabadi MA, Iezadi S, Mardi A. Effects of customer self-audit on the quality of maternity care in Tabriz: A cluster-randomized controlled trial. PloS one. 2018 Oct 11;13(10):e0203255.\" How you categorized PAM result in four level?

Thanks much for sharing the wonderful piece and critical look. We have added the cut-off in the updated document.

Health Literacy

The cut-offs to define "high health literacy level" was determined considering upper quartile and the lower two quartiles as "low health literacy level". This applied to categorize all the five HLQ domains as there was no any standard cut-off.\[Line 186-188\]

PAM

The raw score was calculated using password protected scoresheet provided by Insignia Health and then excel data was imported in SPSS.(21). The raw scores of PAM were converted into four activation levels: (i) Level 1(0.0-47.0): disengaged and overwhelmed, (ii) Level 2(47.1-55.1): becoming aware, but still struggling, (iii) Level 3(55.2-72.4): taking action and, (iv) Level 4(72.5-100.0): maintaining behaviors and pushing further.(21, 22)

\[Line 196-200\]

Provide detailed reference for SPSS as \" IBM SPSS Statistics for Windows, version 23 (IBM Corp., Armonk, N.Y., USA)\".

We have included in the revised version.

Please report regression prerequisite in method section and its handling methods.

Based on reviewer and editor remarks, we checked the assumptions of linear regression and we revised our analysis and have used logistic regression.

The statistical analyses were performed using the Statistical Package for Social Sciences (SPSS 23.00)(25).Participant characteristics were summarised as frequency and percentage. Normality of the data was assessed using Shapiro-Wilk test. We used Chi-Square test for univariate analysis and all the independent variables that had p\<0.2 were considered in multivariable regression analysis. Step-wise multivariable logistic regression analysis was used to identify the determinants of poor HL and PA levels and the p-value ≤ 0.05 were considered as significant.

How you test the normality of data to use T-test and ANOVA? What test did you used in case the data were not normal?

The Shapiro-Wilks test was used to investigate the normality of the data and we found no violations of regression assumptions. A significance level of p\<0.05 for all the independent variables with dependent variables (HLQ domains and PAM) in univariate analysis were considered in multivariable regression analysis. Multivariable linear regression analysis was used to assess associations of the independent variable with scores of HLQ scales and PAM separately. \[Page 7\]

A P-value was duplicated in table 2.

Provide B: Unstandardized coefficients, S.E.: Standard error and Beta: Standardized regression coefficients for variable and model Goodness of Fit in table 3.

Analysis is changed in the revised version.

Reviewer 1

Multivariate logistic regression is better statistical analyses in this research than multiple linear regression. It\'s suggest to analysis with multivariate logistic regression and compare the results. Dear Reviewer,

Thanks for your suggestion and we have changed our analysis. Much appreciated for this.

We know that the conditions used by the Independent t-test and One-way Analysis of Variance (ANOVA) are that the data should conform to the normal distribution and the homogeneity of the variance. Has the author conducted the test? If not, use the rank sum test please.-

Analysis is changed in the revised version.

We used Chi-Square test for univariate analysis and all the independent variables that had p\<0.2 were considered in multivariable regression analysis. Step-wise multivariable logistic regression analysis was used to identify the determinants of poor HL and PA levels

The Illness Perception scale indicator is not statistically analysed in Tables 1 and 2. Please explain why it included in Table 3 is.

4\. Page 13, the authors describe the majority of the participants had a high of illness burden (BIPQ mean 49.83, SD= 8.86), but it is unclear as to the purpose of including this number.

We have included in results section as: The majority of the participants had a high of illness burden (BIPQ mean 49.83, SD= 8.86).

Thank you for very much for your sharp look.

In this revised version we have included it Table1,2 and Table 3.

Page 14, the authors do not provide information on whether the overall model was significant or accompanying descriptions of effect size, For example: Square value of R. Analysis is changed in the revised version.

Models are adjusted for all the included variables in logistic regression.
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The authors present a paper addressing the levels and determinants of health literacy and patient activation in multimorbid COPD patients in rural Nepal. Health literacy is a very important subject to reduce the impact of chronic diseases in health systems. The results are relevant to the community chosen for this study. Although the subject is interesting the paper does not read well. There are misspellings throughout the text that should be corrected. In measurement section the text is not clear. What do the authors mean by items? Thanks much for noting our misspellings. We have worked on the misspellings throughout the paper. Items mean the questions in each domain.
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Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.
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The reviewers find the work of merit but have requested some additions and revisions.==============================

We would appreciate receiving your revised manuscript by Mar 15 2020 11:59PM. When you are ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>
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Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.
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Kamal Gholipour, PhD

Academic Editor
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\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#3: (No Response)

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#3: Partly

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#3: No

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#3: The manuscript entitled \'Levels and determinants of health literacy and patient activation among multi-morbid COPD people in rural Nepal: Findings from a cross-sectional study\' with the aim to examine the levels and determinants of HL and PA among the multi-morbid COPD patients in Nepal.

The manuscript requires further improvement.

Comments

Page 4 Line 143, the sample size calculation was based on knowledge of self-management. What was the prevalence figure contributed by HL and PA respectively?

Page 5, for the subjects selection into the study what was the minimum education attainment and how to ensure that the subjects understand the study and know what they have been asked?

Page 5 Line 145, the total number of RMs in Sunsari District to be stated.

Page 5 Line 158, what about the level of understanding on the subject matter of the study?

Page 5 Line 159-260, the sentence can be further improved.

Page 6 Line 210, brief IPQ to be written as BIPQ.

Questionnaires

There was no information if the Nepalese version questionnaires (HLQ, PAM, BIPQ) have been validated. The translated questionnaires require a process of validation. If the Nepalese questionnaires were used and validated, it has to be cited and referenced and all interviews to be conducted by referring to the Nepalese version questionnaires copies.

Statistical analyses

Page 7 Line 221-222, proper citation including publisher name to be provided.

Page 7 Line 225, the actual Step wise method and actual name of the statistical test (e.g. whether via GLM, logistic regression tab etc) in the SPSS to be stated.

Page 7 Line 226, coding for category HL and PA levels to be stated. Sub domains to be stated if analyzed.

Page 7, information on missing data to be reported if any.

Results

Table 1, uneducated and educated to be clearly defined. The age category interval inconsistent and how are they categorized? HPS, HIS, SS, AE, UHI and PAM to be denoted in the table footnote. Title to include the word baseline. Table requires cosmetic improvement.

Table 2, the presentation of the table requires improvement including cosmetic changes with the p value in the last column and presented in landscape form if space is limited. n (%) to be labelled. The two rows of Total illness perception scale to be merged and clearly separated from other rows. Technically p value cannot be zero (to use symbol \< ). HPS, HIS, SS, AE, UHI and PAM to be denoted in the table footnote.

More detail information on the estimates, model summary/fit, multicollinearity issue (if any), any adjustment to the p value/alpha level (if any), whether interaction was explored in the analyses to be provided/stated or discussed.

There are numerous typographical errors which require editing.

Here are some examples.

i\) Citation to follow journal format i.e. .\[ \] etc

ii\) US\$ to be written as USD

iii\) table to be written as Table (standardization purposes)

iv\) Line 171, five s

v\) Line 200 further. (22, 23).

vi\) Line 91, Line 106, Line 222, Line 262, Line 234, Line 294, Line 325 spacing typo e.g. 43%.(5,6). \' (25).Participants Health literacy(26) smoking).The Australia,(35) The Netherlands(36), and USA(37) (43, 44). The

vii\) Line 204, products..

viii\) ( AOR), space to be omitted.

For those p values with 0.05, another decimal point to be provided to indicate if the p value is equivalent to p=0.05 or smaller/larger than 0.05.

The list of references requires revision and to follow journal format.

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#3: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0233488.r004

Author response to Decision Letter 1

20 Feb 2020

Reviewer remarks Authors response

Page 4 Line 143, the sample size calculation was based on knowledge of self-management. What was the prevalence figure contributed by HL and PA respectively?

As there was no study on HL and PA in Nepal, and we use the prevalence of self-management in the sample size calculation. This was chosen because both HL and PA contribute to the self-management of conditions.

Page 5, for the subjects selection into the study what was the minimum education attainment and how to ensure that the subjects understand the study and know what they have been asked?. There was no education attainment criterion for subject selection into the study. The study was conducted in a rural setting where the majority of the peoples were uneducated, and the same was revealed from our study (nearly 70%). In order to ensure that the participants can easily understand the study and the employed instruments, a two-day hands-on training was provided to the research assistants \[in both Maithili (a local language spoken by chunks in a rural setting) and a Nepali language\] in the community setting. This included field activities where they explained the questions and checked understanding. In the pilot, we checked responses for inconsistency and did not find any evidence of inconsistency.

Page 5 Line 145, the total number of RMs in Sunsari District to be stated.

Six rural municipalities have been added to the updated manuscript

Page 5 Line 158, what about the level of understanding on the subject matter of the study? The informed consent form was read by the research assistants for those who were unable to read. All of the participants were informed that they were free to withdraw or opt out at any point during the interview. Prior to the interview, written informed consent was obtained from all literate participants, and thumb impressions were obtained from illiterate participants

Page 5 Line 159-160, the sentence can be further improved Study participants with a hearing disability, severe cognitive disorder, kidney disease, a history of stroke or diagnosed heart attack, and with a terminal illness such as cancer were excluded from the study.

Page 6 Line 210, brief IPQ to be written as BIPQ. In line with your remarks, we have corrected it as BIPQ in the revised manuscript

There was no information if the Nepalese version questionnaires (HLQ, PAM, BIPQ) have been validated. The translated questionnaires require a process of validation. If the Nepalese questionnaires were used and validated, it has to be cited and referenced, and all interviews to be conducted by referring to the Nepalese version questionnaires copies.

The HLQ and BIPQ have been used in a previous study in Nepal. PAM has been validated, and we are writing a manuscript for PAM validation(level of internal consistency is good (α = 0.88)).

The link to HLQ and BIPQ study in Nepal:

1\. <https://www.ncbi.nlm.nih.gov/pubmed/30412262> (HLQ)

2\. <https://core.ac.uk/download/pdf/145237476.pdf> (BIPQ)

All interviews were conducted using Nepalese version questionnaires of HLQ, BIPQ and PAM.

In line with your remarks, we have revised our paper with proper citation.

Statistical analyses

Page 7 Line 221-222, proper citation including publisher name to be provided.

Page 7 Line 225, the actual Step wise method and actual name of the statistical test (e.g. whether via GLM, logistic regression tab etc) in the SPSS to be stated.

Page 7 Line 226, coding for category HL and PA levels to be stated. Sub domains to be stated if analyzed. More detail information on the estimates, model summary/fit, multicollinearity issue (if any), any adjustment to the p value/alpha level (if any), whether interaction was explored in the analyses to be provided/stated or discussed. The statistical analyses were performed using the IBM Statistical Package for Social Sciences (SPSS 23.00)(29). Participant characteristics were summarised as frequency and percentage. Normality of the data was assessed using the Shapiro-Wilk test. The inter-quartile range was calculated for all included HLQ domains separately, where the upper quartile cut-offs were used to define \"high health literacy level\" and the lower two quartiles as \"low health literacy level\". The raw scores for PAM were categorized into four activation levels (Level 1, 2, 3, and 4) based on a standard cut-off of PAM where level 1 was labeled as \"poor activation stage\" and Level 2 to 4 as \"activation\" stage. We used the Chi-Square test for univariate analysis was conducted for all included five domains of HLQ and the PAM where all the independent variables that had p\<0.2 were considered in multivariable regression analysis. We assessed the multicollinearity of covariates using Variance Inflation Factors (VIFs). The VIFs for all covariates that were included in the logistic regression analysis were less than 2.0. Backward elimination step-wise multivariable logistic regression analysis was used to identify the determinants of poor HL and PA levels, and the p-value ≤ 0.05 were considered as significant.

Page 7, information on missing data to be reported if any.

There was no missing data in this study

Results

Table 1, uneducated and educated to be clearly defined. The age category interval inconsistent and how are they categorized? HPS, HIS, SS, AE, UHI and PAM to be denoted in the table footnote. Title to include the word baseline. Table requires cosmetic improvement.

Education status is defined in the revised table and age category is revised.

HPS, HIS, SS, AE, UHI and PAM is denoted in the table footnote.

Cosmetic improvement is done.

Table 2, the presentation of the table requires improvement including cosmetic changes with the p value in the last column and presented in landscape form if space is limited. n (%) to be labelled. The two rows of Total illness perception scale to be merged and clearly separated from other rows. Technically p value cannot be zero (to use symbol \< ). HPS, HIS, SS, AE, UHI and PAM to be denoted in the table footnote.

Thank you very much for your sharp look. In line with your remarks, we have revised the manuscript

There are numerous typographical errors which require editing.

Here are some examples.

i\) Citation to follow journal format i.e. .\[ \] etc

ii\) US\$ to be written as USD

iii\) table to be written as Table (standardization purposes)

iv\) Line 171, five s

v\) Line 200 further. (22, 23).

vi\) Line 91, Line 106, Line 222, Line 262, Line 234, Line 294, Line 325 spacing typo e.g. 43%.(5,6). \' (25).Participants Health literacy(26) smoking).The Australia,(35) The Netherlands(36), and USA(37) (43, 44). The

vii\) Line 204, products..

viii\) ( AOR), space to be omitted. Typographical errors are corrected and paper is thoroughly edited.

For those p values with 0.05, another decimal point to be provided to indicate if the p-value is equivalent to p=0.05 or smaller/larger than 0.05.

We have revised the table, and your valuable suggestions are considered in the paper.

The list of references requires revision and to follow journal format Corrected in line with Plos One format

10.1371/journal.pone.0233488.r005
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Dear Mr Yadav,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

==============================

We would appreciate receiving your revised manuscript by Apr 30 2020 11:59PM. When you are ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Kamal Gholipour, PhD

Academic Editor

PLOS ONE

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#3: (No Response)

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#3: (No Response)

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#3: No

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#3: (No Response)

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#3: (No Response)

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#3: The authors have put in effort to address the comments.

Minor comments

For the logistic regression, information on goodness of fit test/model fit to be stated.

Please explain how the multicollinearity was performed for variables more than 2 categories in SPSS? The coding information for all variables to be provided.

Was interaction explored in the analysis?

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#3: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0233488.r006

Author response to Decision Letter 2

25 Mar 2020

Reviewer remarks Authors response

For the logistic regression, information on goodness of fit test/model fit to be stated. Thank you very much. Have stated in the statistical analysis section:

The Hosmer-Lemeshow test was used for goodness of fit in the logistic regression model.

Please explain how the multicollinearity was performed for variables more than 2 categories in SPSS. The coding information for all variables to be provided

We choose a reference category with a larger fraction of the cases and have created a dummy variable for a viable that represent a categorical variable with three or more categories.( <https://statisticalhorizons.com/multicollinearity>)

Coding Information are:

HPS: 0: high, 1: low

HIS:0: high, 1: low

SS: 0: high, 1: low

AE: 0: high, 1: low

UHI: 0: high, 1: low

PAM: 0: high, 1: poor

Gender: Male:0, Female:1

Age category: ≤40:0, 41-55:1, ≥56:2

Education status: Educated:0, Uneducated:1

Marital status: Married:0, Others:1

Ethnicity: Higher Caste:0, Indigenous:1, Dalits:2

Occupation: Professional:0, Farmer:1, Factory worker:2

Family level income: \<20,000: 1, \>20,000:0

Use of tobacco products: No:0, Yes:1

Presence of co-morbidity: At least one: 1, Two or more:0

Was interaction explored in the analysis? Yes, we explored the interaction and could not find any.

10.1371/journal.pone.0233488.r007
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Dear Dr. Yadav,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at <https://www.editorialmanager.com/pone/>, click the \"Update My Information\" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

With kind regards,

Wen-Jun Tu

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#3: (No Response)

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#3: (No Response)

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#3: The Hosmer-Lemeshow test outcome i.e p \> 0.05 (indicating model is fit) to be denoted in the result section.

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#3: No
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Dear Dr. Yadav:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

For any other questions or concerns, please email <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE.

With kind regards,

PLOS ONE Editorial Office Staff
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Dr. Wen-Jun Tu

Academic Editor

PLOS ONE
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